Section 382 Rights Agreement Dated as of May 1, 2014 by and between ENZON PHARMACEUTICALS, INC. and CONTINENTAL STOCK TRANSFER & TRUST COMPANY as Rights AgentSection 382 Rights Agreement • May 1st, 2014 • Enzon Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledMay 1st, 2014 Company Industry JurisdictionThis Section 382 Rights Agreement, dated as of May 1, 2014 (this “Agreement”), is made and entered into by and between Enzon Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation, as rights agent (the “Rights Agent”).